Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Depreciation & Amortization (CF) (2016 - 2026)

Intellia Therapeutics has reported Depreciation & Amortization (CF) over the past 12 years, most recently at $2.2 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 11.85% to $2.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Mar 2026, down 7.6% year-over-year, with the annual reading at $9.8 million for FY2025, 4.85% down from the prior year.
  • Depreciation & Amortization (CF) was $2.2 million for Q1 2026 at Intellia Therapeutics, down from $2.4 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $2.6 million in Q2 2024 and troughed at $1.8 million in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $2.4 million (2025), against an average of $2.3 million.
  • Year-over-year, Depreciation & Amortization (CF) increased 21.95% in 2024 and then fell 11.85% in 2026.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.1 million in 2022, then rose by 19.77% to $2.5 million in 2023, then rose by 5.43% to $2.6 million in 2024, then fell by 7.19% to $2.4 million in 2025, then fell by 8.74% to $2.2 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Depreciation & Amortization (CF) are $2.2 million (Q1 2026), $2.4 million (Q4 2025), and $2.4 million (Q3 2025).